ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders.
about
A concise review of pulmonary sarcoidosisGenetic interstitial lung diseaseCurrent and emerging pharmacological treatments for sarcoidosis: a reviewGenotyping in the MHC locus: potential for defining predictive markers in sarcoidosisTh1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosisGranuloma formation in pulmonary sarcoidosisDistribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosisAdvances in the diagnosis and treatment of sarcoidosisManagement of extrapulmonary sarcoidosis: challenges and solutionsIntra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathyChitotriosidase in the Pathogenesis of Inflammation, Interstitial Lung Diseases and COPDDual Inhibition of Rip2 and IRAK1/4 Regulates IL-1β and IL-6 in Sarcoidosis Alveolar Macrophages and Peripheral Blood Mononuclear CellsImmune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosisIs there a uniform approach to the management of diffuse parenchymal lung disease (DPLD) in the UK? A national benchmarking exercise.Quantitative ultrasound does not identify patients with an inflammatory disease at risk of vertebral deformities.Arterial Carboxyhemoglobin Measurement Is Useful for Evaluating Pulmonary Inflammation in Subjects with Interstitial Lung Disease.Dermatologic conditions in patients of color who are pregnantDifferent activity of the biological axis VEGF-Flt-1 (fms-like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: a bronchoalveolar lavage study.A rare case of pulmonary tuberculosis with simultaneous pulmonary and skin sarcoidosis: a case reportRepository corticotropin for Chronic Pulmonary Sarcoidosis.Sarcoidosis: sex-dependent variations in presentation and management.Sarcoidosis incidentally diagnosed: a case report.Investigation of Toll-like receptors in the pathogenesis of fibrotic and granulomatous disorders: a bronchoalveolar lavage study.Pain and autonomic dysfunction in patients with sarcoidosis and small fibre neuropathy.Infectious and noninfectious granulomatosis in patient with multiple sclerosis: diagnostic dilemmas and followup.A predictive tool for an effective use of (18)F-FDG PET in assessing activity of sarcoidosis.Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity.Development of sarcoidosis following completion of treatment for hepatitis C with pegylated interferon-{alpha}2a and ribavirin: a case report and literature review.Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4- axis in sarcoidosis patientsPreliminary characterizations of a serum biomarker for sarcoidosis by comparative proteomic approach with tandem-mass spectrometry in ethnic Han Chinese patients.M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosisUtility of endoscopic ultrasound-guided transbronchial fine-needle cytology in the diagnosis of sarcoidosis: A Saudi experience.BTNL2 gene SNPs as a contributing factor to sarcoidosis pathogenesis in a cohort of Greek patientsOverview of neurosarcoidosis: recent advances.Differential inflammatory microRNA and cytokine expression in pulmonary sarcoidosis.Subcutaneous sarcoidosis: a rare involvement of the paralateral nasal region.Genetic profiles of Propionibacterium acnes and identification of a unique transposon with novel insertion sequences in sarcoid and non-sarcoid isolates.Early-onset childhood sarcoidosis with incidental multiple enchondromatosis.A case series in patients with enteropathy and granulomatous diseasesThe effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis
P2860
Q24609077-F4FB39F8-0457-44A0-A5A8-DC302EFC2BC4Q24626239-7451A2BB-9EC8-407D-9349-2E3EA099D72AQ24633717-BAC146CD-88BA-42FD-BEC8-40FD66D5B34CQ24799118-536DF509-0F13-4641-A3F2-625FA786BE4EQ24810989-F5598A91-8DA1-4ABD-AD83-DF3510E8266AQ26863703-4352602D-09FB-4121-94DD-2A553208B90EQ26864740-C9D9C66C-E062-49EF-8BB3-F5225FA72354Q27026974-CB6A311A-A1FC-4BE8-A068-53490265B101Q28066968-F95912AF-E39F-4FA1-B427-C281DB61422AQ28067623-F73BC4BC-241D-4B47-9041-D9D8DEF644F3Q28384802-7E57C45A-F892-4086-8527-A938695164DCQ28385953-9DBDEEBA-F865-44C5-BE36-5D8B06ECD39DQ30432636-F730189D-58AD-4342-B6BA-BCB11116C9FEQ33278156-01833987-C9CF-4579-B7E9-6CD5390FA6F6Q33336251-BBF1A14B-1766-4DDF-95EA-CE5C07B6E51DQ33619174-58910D69-5E91-4635-929D-E16F10A5B019Q33641455-41AED248-FBD3-4E2A-B47E-13FA287A87FAQ33652319-4DC8FF32-87E3-4A4B-A6E7-F342068CBA70Q33657822-F0CBBFEC-997B-46D1-8193-6CAE2D702F12Q33705377-46325B6F-B442-4118-AE04-370D3B3E0868Q33766864-B5F0FCD0-3719-438F-9223-D7E845DDA428Q33944478-9B76077C-1208-411C-9A12-480372D016ABQ34243304-D90E0DF8-CBD7-4AA4-93C4-81260BD516FAQ34361737-8FF4BFDE-33D6-485F-8689-D1A227D15FBCQ34393684-1FCEB854-55FD-4773-A731-5B5474736238Q34414996-13289477-71FD-424D-87E0-C19C0F5A6728Q34425775-72346671-09E0-487B-836D-E8294C25D42AQ34427329-A51CDE83-DD1E-407E-9DDD-DBBC99EAE204Q34488513-88076C9A-5B1C-4D76-ACCD-3D8525A8E9CDQ34582445-5C33235A-0E22-43C3-BA8E-96479E692080Q34756244-C357B2DA-D540-4BA8-ADD3-49EE55FD6977Q34779907-8B662DC5-A953-4E5E-BE10-326919C45716Q34878705-4A89AB47-251E-4357-AE78-E38948841708Q35089244-69BD81B4-857A-417F-8B16-6450C8615F89Q35176239-8E1FCB9C-2769-4E24-A9F9-F95079FC8388Q35470224-B2944661-8E6E-42A5-97B1-CC5335F81932Q35596162-E0F7FB85-01A5-4816-965F-941B71AF6A2BQ35639080-DE6C0112-A4C5-4FB7-9B1E-6FF7E357FBE9Q35639725-EEE6DB27-B84A-4DA5-B2EC-59E54BD44465Q35660312-4022F3E6-79D6-4EBB-8880-5342D32AD048
P2860
ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
ATS/ERS/WASOG statement on sar ...... other Granulomatous Disorders.
@ast
ATS/ERS/WASOG statement on sar ...... other Granulomatous Disorders.
@en
type
label
ATS/ERS/WASOG statement on sar ...... other Granulomatous Disorders.
@ast
ATS/ERS/WASOG statement on sar ...... other Granulomatous Disorders.
@en
prefLabel
ATS/ERS/WASOG statement on sar ...... other Granulomatous Disorders.
@ast
ATS/ERS/WASOG statement on sar ...... other Granulomatous Disorders.
@en
P2093
P1476
ATS/ERS/WASOG statement on sar ...... other Granulomatous Disorders.
@en
P2093
G Semenzato
G W Hunninghake
J F Cordier
M Kitaichi
O P Sharma
P304
P577
1999-09-01T00:00:00Z